Citation: Zhang Yan, Wang Yunyun, Zhao Yuxun, Zhang Chenglong, Gu Wen, Wang Zhonglong, Zhu Yongqiang, Wang Shifa. Camphor-Based Thiosemicarbazone Analogues Induced G2 Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species (ROS)-Mediated Mitochondrial Pathway in Human Breast Cancer Cells[J]. Chinese Journal of Organic Chemistry, ;2020, 40(8): 2374-2386. doi: 10.6023/cjoc202001021 shu

Camphor-Based Thiosemicarbazone Analogues Induced G2 Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species (ROS)-Mediated Mitochondrial Pathway in Human Breast Cancer Cells

  • Corresponding author: Zhu Yongqiang, zhyqscu@163.com Wang Shifa, wangshifa65@163.com
  • Received Date: 14 January 2020
    Revised Date: 22 May 2020
    Available Online: 8 June 2020

    Fund Project: Natural National Science Foundation of China 31470592Doctorate Fellowship Foundation of Nanjing Forestry University 31470592Key Technology of Green Processing and Efficient Utilization on Oleoresin 2016YFD0600804Project supported by the Doctorate Fellowship Foundation of Nanjing Forestry University, the Natural National Science Foundation of China (No. 31470592), the University Science Research Project of Jiangsu Province (No. 14KJ220001) and the Key Technology of Green Processing and Efficient Utilization on Oleoresin (No. 2016YFD0600804)University Science Research Project of Jiangsu Province 14KJ220001

Figures(7)

  • 22 novel camphor-based thiosemicarbazone derivatives were synthesized using camphor-based thiosemicarbazone as material and their structures were determined by 1H NMR, 13C NMR and HRMS. The crystal structure of 2-(3-(pyridin-4-ylmethylene)-1, 7, 7-trimethylbicyclo[2.2.1]heptan-2-ylidene)hydrazinecarbothioamide (3n) was determined by single crystal X-ray diffraction. The derivatives were screened in vitro for anticancer activities against human breast cancer cell line (MDA-MB-231), human lung adenocarcinoma cell line (A549), human multiple myeloma cell line (RPMI-8226) and toxicity against a normal human cell line (GES-1) by 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). It was found that majority of the tested analogs showed moderate to significant antitumor activity against selected cancer cell lines. Noticeably, 2-(3-(anthracen-9-ylmethylene)-1, 7, 7-trimethylbicyclo[2.2.1]heptan-2-ylidene)-hydrazinecarbothioamide (3s) exhibited selective anti-tumor activities against MDA-MB-231 cells (IC50=3.90±0.04 μmol·L-1) and low toxicity to GES-1 cells (IC50>50 μmol·L-1). In the process of exploring the underlying mechanism of 3s, it was found that compound 3s could cause G2 phase arrest and apoptosis in MDA-MB-231 cells by overproduction of intracellular reactive oxygen species and collapse of mitochondrial membrane potential. The measured results were confirmed by western blot assay.
  • 加载中
    1. [1]

      Xu Z., Zhao S. J., Liu Y.Eur. J. Med. Chem., 2019, 183:111700.
       

    2. [2]

      Zhang L., Xu Z.Eur. J. Med. Chem., 2019, 181:111587.
       

    3. [3]

      Magalhaes Moreira D. R., de Oliveira A. D., Teixeira de Moraes Gomes P. A., de Simone C. A., Villela F. S., Ferreira R. S., Leite A. C.Eur. J. Med. Chem., 2014, 75:467.
       

    4. [4]

      De Melos J. L., Torres-Santos E. C., Faioes Vdos S., Del Cistia Cde N., Sant'Anna C. M., Rodrigues-Santos C. E., Echevarria A.Eur. J. Med. Chem., 2015, 103:409.
       

    5. [5]

      Linciano P., Moraes C. B., Alcantara L. M., Franco C. H., Pascoalino B., Freitas-Junior L. H., Costi M. P.Eur. J. Med. Chem., 2018, 146:423.
       

    6. [6]

      El-Sharief M. A., Abbas S. Y., El-Bayouki K. A., El-Gammal E. W.Eur. J. Med. Chem., 2013, 67:263.
       

    7. [7]

      Zhang X., Guo H., Li Z., Song F., Wang W., Dai H., Wang J.Eur. J. Med. Chem., 2015, 101:419.
       

    8. [8]

      Banerjee D., Yogeeswari P., Bhat P., Thomas A., Srividya M., Sriram D.Eur. J. Med. Chem., 2011, 46:106.
       

    9. [9]

      Kesel A. J.Eur. J. Med. Chem., 2011, 46:1656.
       

    10. [10]

      Chavarria G. E., Horsman M. R., Arispe W. M., Kumar G. D., Chen S. E., Strecker T. E., Trawick M. L.Eur. J. Med. Chem., 2012, 58:568.
       

    11. [11]

      Pervez H., Khan N., Zaib S., Yaqub M., Naseer M. M., Tahir M. N., Iqbal J.Bioorg. Med. Chem., 2017, 25:1022.
       

    12. [12]

      Song S., You A., Chen Z., Zhu G., Wen H., Song H., Yi W.Eur. J. Med. Chem., 2017, 139:815.
       

    13. [13]

      De Oliveira J. F., Lima T. S., Vendramini-Costa D. B., de Lacerda Pedrosa S. C. B., Lafayette E. A., da Silva R. M. F., de Lima M.Eur. J. Med. Chem., 2017, 136:305.
       

    14. [14]

      Vandresen F., Falzirolli H., Almeida Batista S. A., da Silva-Giardini A. P., de Oliveira D. N., Catharino R. R., da Silva C. C.Eur. J. Med. Chem., 2014, 79:110.
       

    15. [15]

      Lukmantara A. Y., Kalinowski D. S., Kumar N., Richardson D. R.Bioorg. Med. Chem. Lett., 2013, 23:967.
       

    16. [16]

      Rao V. A., Klein S. R., Agama K. K., Toyoda E., Adachi N., Pommier Y., Shacter E. B.Cancer Res., 2009, 69:948.
       

    17. [17]

      Malarz K., Mrozek-Wilczkiewicz A., Serda M., Rejmund M., Musiol R.Oncotarget, 2018, 9:17689.
       

    18. [18]

      Lovejoy D. B., Richardson D. R.Blood, 2002, 100:666.
       

    19. [19]

      Da Silva A. P., Martini M. V., de Oliveira C. M., Cunha S., de Carvalho J. E., Ruiz A. L., da Silva C. C.Eur. J. Med. Chem., 2010, 45:2987.
       

    20. [20]

      Bao M., Yang Y., Gu W., Xu X., Cao M., Wang S.Chin. J. Org. Chem., 2014, 34:2146(in Chinese).
       

    21. [21]

      Sun N., Wang X., Ding Z., Zhang Q., Xu X., Xu H., Wang S.Chin. J. Org. Chem., 2016, 36:2489(in Chinese).
       

    22. [22]

      Rui J., Cai T., Yang J., Yang Y., Xu X., Wang S.J. Nanjing. For. Univ., 2017, 41:149(in Chinese).
       

    23. [23]

      Ma C., Wang Y., Dong F., Wang Z., Zhao Y., Shan Y., Wang S.Chem. Biol. Drug Des., 2019, 94:1457.
       

    24. [24]

      Wang Y., Wang Z., Kuang H., Zhang Y., Gu W., Zhu Y., Wang S.Chem. Biol. Drug Des., 2019, 94:1281.
       

    25. [25]

      Sokolova A. S., Yarovaya O. C., Korchagina D. V., Zarubaev V. V., Tretiak T. S., Anfimov P. M., Salakhutdinov N. F.Bioorg. Med. Chem., 2017, 127:661.
       

    26. [26]

      Stavrakov G., Valcheva V., Philipova I., Doytchinova I.Eur. J. Med. Chem., 2013, 70:372.
       

    27. [27]

      Sokolova A. S., Yarovaya O. C., Korchagina D. V., Zarubaev V. V., Tretiak T. S., Anfimov P. M., Salakhutdinov N. F.Bioorg. Med. Chem., 2014, 22:2141.
       

    28. [28]

      Kuranov S. O., Tsypysheva I. P., Khvostov M. V., Zainullina L. F., Borisevich S. S., Vakhitova Y. V., Salakhutdinov N. F.Bioorg. Med. Chem., 2018, 26:4402.
       

    29. [29]

      Hossain M., Das U., Dimmock J. R.Eur. J. Med. Chem., 2019, 183:111687.
       

    30. [30]

      Dan W., Dai J.Eur. J. Med. Chem., 2020, 187:111980.
       

    31. [31]

      Zhu M., Wang J., Xie J., Chen L., Wei X., Jiang X., Bao M., Qiu Y., Chen Q., Li W., Jiang C., Zhou X., Jiang L., Qiu P., Wu J.Eur. J. Med. Chem., 2018, 157:1395.
       

    32. [32]

      Liu C., Wen R., He M., Yi X., Ye X., Fang L.Chin. J. Appl. Chem., 2017, 38:900(in Chinese).
       

    33. [33]

      Zhang H., Qian Y., Zhu D., Yang X., Zhu H.Eur. J. Med. Chem., 2011, 46:4702.
       

    34. [34]

      Simon H. U., Haj-Yehia A., Levi-Schaffer F.Apoptosis, 2000, 5:415.
       

    35. [35]

      Circu M. L., Aw T. Y.Free Radical Biol. Med., 2010, 48:749.
       

    36. [36]

      Dharmaraja A. T.J. Med. Chem., 2017, 60:3221.
       

    37. [37]

      Yamada Y., Harashima H.Adv. Drug Delivery Rev., 2008, 60:1439.
       

    38. [38]

      Galluzzi L., Zamzami N., de La Motte Rouge T., Lemaire C., Brenner C., Kroemer G.Apoptosis, 2007, 12:803.
       

    39. [39]

      Jin Z., El-Deiry W. S.Cancer Biol. Ther., 2005, 4:139.
       

    40. [40]

      Martinou J. C., Desagher S., Antonsson B.Nat. Cell Biol., 2005, 2:41.
       

    41. [41]

      Xiong S., Mu T., Wang G., Jiang X.Protein Cell, 2014, 5:737.
       

  • 加载中
    1. [1]

      Qing-Hua Chen , Da-Yong Hou , Ni-Yuan Zhang , Jia-Qi Wang , Rui Zheng , Xing-Jie Hu , Xiu-Hai Wu , Li Yi , Ying-Jin Zhang , Guang-Xu Zhang , Yu-Juan Gao , Ben-Li Song , Rui Wang , Jian-Xiao Liang , Ming-Ze Cai , Yu Wang , Jia-Yuan Niu , Li-Ying Wang , Yang Yang , Hao-Ze Li , Hong-Wei An , Lei Wang , Yuliang Zhao , Hao Wang . Systemic study on anti-tumor activity of HER2 induced peptide-drug conjugate clustering in xenograft tumor models. Chinese Chemical Letters, 2026, 37(5): 111257-. doi: 10.1016/j.cclet.2025.111257

    2. [2]

      Zhongyu Wang , Lijun Wang , Huaixin Zhao . DNA-based nanosystems to generate reactive oxygen species for nanomedicine. Chinese Chemical Letters, 2024, 35(11): 109637-. doi: 10.1016/j.cclet.2024.109637

    3. [3]

      Yirou Wang , Futing Yang , Jun Wang , Xinghua Liao , Chun Song , Michał Nowicki , Roman Szewczyk , Na Peng . Glutathione-activated mitochondria-targeting nanosystem overcoming ferroptosis defence for dual synergism with apoptosis to enhance anti-tumor efficacy of sonodynamic therapy. Chinese Chemical Letters, 2026, 37(8): 111771-. doi: 10.1016/j.cclet.2025.111771

    4. [4]

      Huijuan Zhang , Chenglin Liang , Xinyi Ding , Meng Zhang , Siyu Lu , Lin Hou . Manganese-based nano-delivery system for sensitized anti-tumor immunotherapy via combined autophagy inhibition. Chinese Chemical Letters, 2025, 36(7): 110525-. doi: 10.1016/j.cclet.2024.110525

    5. [5]

      Weiqun Li , Ming-Jie Dong , Haibing Dai , Shanming Lu , Ran Luo , Jiahui Cao , Fan Zhang , Lin Mei , Jianbo Yu . Application of mitochondrial miRNA-204 nanoprobes in Alzheimer's disease treatment by clearing reactive oxygen species-mediated autophagy. Chinese Chemical Letters, 2025, 36(8): 110614-. doi: 10.1016/j.cclet.2024.110614

    6. [6]

      Shuangshuang GAI , Jixiang CAI , Moya YANG , Haijuan WU , Shuzhen FENG , Ming JIANG . Endoplasmic reticulum stress and mitochondrial apoptosis in thiosemicarbazone copper(Ⅱ) complex-triggered triple-negative breast cancer cell death. Chinese Journal of Inorganic Chemistry, 2026, 42(5): 1073-1084. doi: 10.11862/CJIC.20250328

    7. [7]

      Qianyun Ye , Yuanyuan Liang , Yuhe Yuan , Xiaohuan Sun , Liqi Zhu , Xuan Wu , Jie Han , Rong Guo . pH-responsive chiral supramolecular cysteine-Zn2+-indocyanine green assemblies for triple-level chirality-specific anti-tumor efficacy. Chinese Chemical Letters, 2025, 36(5): 110432-. doi: 10.1016/j.cclet.2024.110432

    8. [8]

      Qing Liu , Tangxin Xiao , Zhouyu Wang , Leyong Wang . Reactive oxygen species generation by organic materials for efficient photocatalysis. Chinese Chemical Letters, 2025, 36(10): 111504-. doi: 10.1016/j.cclet.2025.111504

    9. [9]

      Bingkun Huang , Zelin Wu , Jing Zhang , Yanbiao Shi , Chuan-Shu He , Zhaokun Xiong , Bo Lai . Is the choice of quencher appropriate for exploring reactive oxygen species in advanced oxidation processes?. Chinese Chemical Letters, 2026, 37(3): 111537-. doi: 10.1016/j.cclet.2025.111537

    10. [10]

      Mengyi Xi , Kaiqing Wu , Jingjing Chen , Yanfei Shen , Songqin Liu , Ran Chen , Yuanjian Zhang . Recent advances of analytical methods for intermediates of reactive oxygen species in electrocatalytic oxygen reduction reactions. Chinese Chemical Letters, 2026, 37(5): 111915-. doi: 10.1016/j.cclet.2025.111915

    11. [11]

      Limin Jin , Jie Xu , Huayue Zhu , Chunjuan Li , Zhengfeng Hu , Qi Wang . Recent progress on the (photo)electrocatalytic molecular oxygen activation in reactive oxygen species generation for environmental remediation. Chinese Chemical Letters, 2026, 37(9): 111865-. doi: 10.1016/j.cclet.2025.111865

    12. [12]

      Chanqi Ye , Jia Zhang , Jie Shen , Ruyin Chen , Qiong Li , Peng Zhao , Dong Chen , Jian Ruan . Attractive Pickering emulsion gel loaded with oxaliplatin and lactate dehydrogenase inhibitor increases the anti-tumor effect in hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(7): 110519-. doi: 10.1016/j.cclet.2024.110519

    13. [13]

      Yuanyi Zhou , Ke Ma , Jinfeng Liu , Zirun Zheng , Bo Hu , Yu Meng , Zhizhong Li , Mingshan Zhu . Is reactive oxygen species the only way for cancer inhibition over single atom nanomedicine? Autophagy regulation also works. Chinese Chemical Letters, 2024, 35(6): 109056-. doi: 10.1016/j.cclet.2023.109056

    14. [14]

      Chi Zhang , Ning Ding , Yuwei Pan , Lichun Fu , Ying Zhang . The degradation pathways of contaminants by reactive oxygen species generated in the Fenton/Fenton-like systems. Chinese Chemical Letters, 2024, 35(10): 109579-. doi: 10.1016/j.cclet.2024.109579

    15. [15]

      Xiaokang Hou , Huanxin Ma , Mengmeng Zhao , Chunhua Feng , Shishu Zhu . Unveiling role of Cu(Ⅱ) in photochemical transformation and reactive oxygen species production of schwertmannite in the presence of tartaric acid. Chinese Chemical Letters, 2025, 36(7): 110332-. doi: 10.1016/j.cclet.2024.110332

    16. [16]

      Rongrong Zheng , Zuxiao Chen , Qiuyuan Li , Ni Yang , Wenjun Zhang , Chuyu Huang , Linping Zhao , Xin Chen , Hong Cheng , Shiying Li . Endoplasmic reticulum targeting photodynamic oxidizer to boost anti-tumor immunity by intensifying immunogenic cell death in conjunction with IDO1 inhibition. Chinese Chemical Letters, 2025, 36(12): 110865-. doi: 10.1016/j.cclet.2025.110865

    17. [17]

      Yupeng Wang , Xinxin Sun , Jianbin Shi , Zhixiao Zhang , Jin Sun , Cong Luo , Zhonggui He , Shenwu Zhang . Chain architecture-engineered artesunate nanoassemblies target LONP1 to induce oxidative damage for enhanced anti-tumor therapy. Chinese Chemical Letters, 2026, 37(1): 111609-. doi: 10.1016/j.cclet.2025.111609

    18. [18]

      Shuo Chen , Yuxuan Xiang , Qiulin Yang , Shuang Meng , Chuanshu He , Yang Liu , Jing Zhang , Zhaokun Xiong , Peng Zhou , Bo Lai . Amorphous-boron boosted Fenton-like activation of periodate for water remediation: Multiple routes for generating reactive oxygen species. Chinese Chemical Letters, 2026, 37(5): 111838-. doi: 10.1016/j.cclet.2025.111838

    19. [19]

      Jiali Peng , Yu Mei , Shihuai Deng , Yanjun Li , Chenye Fu , Yi Ren , Guochun Lv , Zehua Wang , Xiaoxun Xu , Xiaohui Lu , Bo Lai . FeB-activated peracetic acid for carbamazepine degradation: Generation of multiple reactive oxygen species and a two-stage activation mechanism. Chinese Chemical Letters, 2026, 37(6): 112068-. doi: 10.1016/j.cclet.2025.112068

    20. [20]

      Mingze Sun , Jianhua Qu , Kaige Li , Yue Lei , Jingyi Wang , Juncheng Wang , Yue Tao , Yifan Wang , Ying Zhang . Hydroxylamine-regulated reactive oxygen species generation in an iron-biochar composite activated peracetic acid system for ultra-rapid degradation of atrazine. Chinese Chemical Letters, 2026, 37(12): 112750-. doi: 10.1016/j.cclet.2026.112750

Metrics
  • PDF Downloads(12)
  • Abstract views(2090)
  • HTML views(286)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return